Hostname: page-component-75d7c8f48-cp9qn Total loading time: 0 Render date: 2026-03-23T04:17:17.203Z Has data issue: false hasContentIssue false
  • English
  • Français

End of life distress as an economic issue: The case for psychedelic-assisted therapy – ERRATUM

Published online by Cambridge University Press:  10 March 2026

Michel Dorval Open the ORCID record for Michel Dorval [Opens in a new window] ,
Virginie Audet-Croteau ,
Sue-Ling Chang ,
Florence Moureaux  and
Jason Robert Guertin
Michel Dorval
Affiliation:
Faculty of Pharmacy, Université Laval, Québec City, QC, Canada Department of Oncology, CHU de Québec-Université Laval Research Center, Québec City, QC, Canada Institut de soins palliatifs et de fin de vie Michel-Sarrazin — Université Laval, Québec City, QC, Canada Réseau québécois de recherche en soins palliatifs et de fin de vie (RQSPAL), Québec, QC, Canada
Virginie Audet-Croteau
Affiliation:
Department of Oncology, CHU de Québec-Université Laval Research Center, Québec City, QC, Canada Institut de soins palliatifs et de fin de vie Michel-Sarrazin — Université Laval, Québec City, QC, Canada Réseau québécois de recherche en soins palliatifs et de fin de vie (RQSPAL), Québec, QC, Canada Faculty of Medicine, Université Laval, Québec City, QC, Canada
Sue-Ling Chang
Affiliation:
Department of Oncology, CHU de Québec-Université Laval Research Center, Québec City, QC, Canada Institut de soins palliatifs et de fin de vie Michel-Sarrazin — Université Laval, Québec City, QC, Canada Réseau québécois de recherche en soins palliatifs et de fin de vie (RQSPAL), Québec, QC, Canada
Florence Moureaux
Affiliation:
Patient-Partner
Jason Robert Guertin
Affiliation:
Faculty of Medicine, Université Laval, Québec City, QC, Canada Department of Population Health and Optimal Health Practices, CHU de Québec-Université Laval Research Center, Québec City, QC, Canada
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content. As you have access to this content, full HTML content is provided on this page. A PDF of this content is also available in through the ‘Save PDF’ action button.

Information

Type
Erratum
Information
Palliative & Supportive Care , Volume 24 , 2026 , e83
Check for updates
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0), which permits unrestricted re-use, distribution and reproduction, provided the original article is properly cited.
Copyright
© The Author(s), 2026. Published by Cambridge University Press.

The Publisher apologises for three errors in the author affiliations in the article. These have been corrected in the published article, as follows:

1Faculty of Pharmacy, Université Laval, Québec City, QC, Canada; 2Department of Oncology, CHU de Québec-Université Laval Research Center, Québec City, QC, Canada; 3Institut de soins palliatifs et de fin de vie Michel-Sarrazin — Université Laval, Québec City, QC, Canada; 4Réseau québécois de recherche en soins palliatifs et de fin de vie (RQSPAL), Québec, QC, Canada; 5Faculty of Medicine, Université Laval, Québec City, QC, Canada; 6Patient-Partner and 7Department of Population Health and Optimal Health Practices, CHU de Québec-Université Laval Research Center, Québec City, QC, Canada.

References

Dorval, M, Audet-Croteau, V, Chang, S-L, Moureaux, F, Guertin, JR. End of life distress as an economic issue: The case for psychedelic-assisted therapy. Palliative and Supportive Care. Published by Cambridge University Press, 28 January 2026. doi:10.1017/S1478951526101722Google Scholar